{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:48:54Z","timestamp":1776322134021,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.micpath.2021.105079","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T06:25:01Z","timestamp":1625725501000},"page":"105079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems"],"prefix":"10.1016","volume":"158","author":[{"given":"Alisha Wehdnesday Bernardo","family":"Reyes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-0711","authenticated-orcid":false,"given":"Heejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Xuan Ngoc","family":"Huy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Son Hai","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Keun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wongi","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu Jang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.105079_bib1","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijvsm.2018.01.008","article-title":"Brucellosis: evolution and expected comeback","volume":"6","author":"El-Sayed","year":"2018","journal-title":"Int. J. Vet. Sci. Med."},{"key":"10.1016\/j.micpath.2021.105079_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijfoodmicro.2018.12.009","article-title":"Human brucellosis caused by raw dairy products: a review on the occurrence, major risk factors and prevention","volume":"292","author":"Dadar","year":"2019","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.micpath.2021.105079_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1017\/S0950268815002575","article-title":"Systemic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection","volume":"144","author":"Musallam","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.micpath.2021.105079_bib4","doi-asserted-by":"crossref","first-page":"e0008164","DOI":"10.1371\/journal.pntd.0008164","article-title":"Occupational exposure to Brucella spp.: a systematic review and meta-analysis","volume":"14","author":"Pereira","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2021.105079_bib5","series-title":"Medical Microbiology","article-title":"Brucella","author":"Alton","year":"1996"},{"key":"10.1016\/j.micpath.2021.105079_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1874318801004010109","article-title":"Pathogenesis of Brucella spp","volume":"4","author":"Xavier","year":"2010","journal-title":"Open Vet. Sci. J."},{"key":"10.1016\/j.micpath.2021.105079_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2007.11.023","article-title":"Brucella: a pathogen without classic virulence genes","volume":"129","author":"Seleem","year":"2008","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2021.105079_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fimmu.2017.00691","article-title":"Brucella dysregulates monocytes and inhibits macrophage polarization through LC3-dependent autophagy","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib9","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.4049\/jimmunol.170.11.5607","article-title":"Subversion and utilization of the host cell cyclic adenosine 5\u2019-monophosphate\/protein kinase A pathway by Brucella during macrophage infection","volume":"170","author":"Gross","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/1471-2164-14-426","article-title":"Early transcriptional responses of internalization defective Brucella abortus mutants in professional phagocytes, RAW 264.7","volume":"14","author":"Cha","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.micpath.2021.105079_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/jcp.26035","article-title":"G protein-coupled receptor 84 controls osteoclastogenesis through inhibition of NF-\u03baB and MAPK signaling pathways","volume":"233","author":"Park","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.micpath.2021.105079_bib12","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1021\/acsomega.7b02092","article-title":"6-(ar)alkylamino-substituted uracil derivatives: lipid mimetics with potent activity at the orphan G protein-coupled receptor 84 (GPR84)","volume":"3","author":"Pillaiyar","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.micpath.2021.105079_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/acsmedchemlett.6b00025","article-title":"Design and synthesis of 2-alkylpyrimidine-4,6-diol and 6-alkylpyridine-2,4-diol as potent GPR84 agonists","volume":"7","author":"Liu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.micpath.2021.105079_bib14","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1074\/jbc.M112.420042","article-title":"Medium-chain fatty acid sensing receptor, GPR84 is a proinflammatory receptor","volume":"288","author":"Suzuki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.105079_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12974-017-0970-y","article-title":"Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia","volume":"14","author":"Wei","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.micpath.2021.105079_bib16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3389\/fimmu.2018.01419","article-title":"Activation of the immune-metabolic receptor GPR84 enhances inflammation and phagocytosis in macrophages","volume":"9","author":"Recio","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib17","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s11033-019-04661-6","article-title":"Pro-athrogenic proteoglycanase ADAMTS-1 is down-regulated by lauric acid through PI3K and JNK signaling pathways in THP-1 derived macrophages","volume":"46","author":"Ong","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.micpath.2021.105079_bib18","first-page":"1","article-title":"Therapeutic validation of a n orphan G protein-coupled receptor: the case of GPR84","author":"Marsango","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.micpath.2021.105079_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/ijms22041763","article-title":"Pharmacology of free fatty acid receptors and their allosteric modulators","volume":"22","author":"Grundmann","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.micpath.2021.105079_bib20","first-page":"849","article-title":"Evaluation of oral administration of lauric acid supplement on fasting blood glucose level and pancreatic histomorphological studies in high fat diet\/streptozotocin type 2 diabetic male wistar rats","author":"Alex","year":"2020","journal-title":"J. Diabetes Metabol."},{"key":"10.1016\/j.micpath.2021.105079_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21767\/2386-5180.1000170","article-title":"Antibacterial activity of lauric acid on some selected clinical isolates","volume":"5","author":"Anzaku","year":"2017","journal-title":"Ann. Clin. Lab. Res."},{"key":"10.1016\/j.micpath.2021.105079_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11746-014-2562-7","article-title":"The properties of lauric acid and their significance in coconut oil","volume":"92","author":"Dayrit","year":"2015","journal-title":"J. Am. Oil Chem. Soc."},{"key":"10.1016\/j.micpath.2021.105079_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fvets.2017.00197","article-title":"Outer membrane protein 25 of Brucella activates mitogen-activated protein kinase signal pathway in human trophoblast cells","volume":"4","author":"Zhang","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.micpath.2021.105079_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1189\/jlb.1010550","article-title":"Nitric oxide and redox mechanisms in the immune response","volume":"89","author":"Wink","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2021.105079_bib25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/pathogens9110942","article-title":"Adhesins of Brucella: their roles in the interaction with the host","volume":"9","author":"Bialer","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2021.105079_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.colsurfb.2014.05.002","article-title":"Surface functionalization of titanium substrates with chitosan-lauric acid conjugate to enhance osteoblasts functions and inhibit bacteria adhesion","volume":"119","author":"Zhao","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.micpath.2021.105079_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apjr.2015.06.005","article-title":"Lauric acid abolishes interferon-gamma (IFN-)-induction of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in human macrophages","volume":"4","author":"Lim","year":"2015","journal-title":"Asian Pac. J. Reprod."},{"key":"10.1016\/j.micpath.2021.105079_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.21767\/2386-5180.1000170","article-title":"Antibacterial activity of lauric acid on some selected clinical isolates","volume":"5","author":"Anzaku","year":"2017","journal-title":"Ann. Clin. Lab. Res."},{"key":"10.1016\/j.micpath.2021.105079_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s007050170146","article-title":"Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid","volume":"146","author":"Bartolotta","year":"2001","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2021.105079_bib30","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/jid.2009.93","article-title":"Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris","volume":"129","author":"Nakatsuji","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.micpath.2021.105079_bib31","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3389\/fmicb.2017.02635","article-title":"Lauric acid is an inhibitor of Clostridium difficile growth in vitro and reduces inflammation in a mouse infection model","volume":"8","author":"Yang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2021.105079_bib32","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/IAI.73.5.3178-3183.2005","article-title":"Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness","volume":"73","author":"Jimenez de Bagues","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105079_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/792639","article-title":"Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?","author":"Son","year":"2011","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.micpath.2021.105079_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/cr.2008.37","article-title":"The roles of MAPKs in disease","volume":"18","author":"Lawrence","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.micpath.2021.105079_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/1742-2094-10-47","article-title":"Brucella abortus induces TNF-\u03b1-dependent astroglial MMP-9 secretion through mitogen-activated protein kinases","volume":"10","author":"Migralia","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.micpath.2021.105079_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1462-5822.2003.00263.x","article-title":"Macrophage signaling upon mycobacterial infection: the MAP kinases lead the way","volume":"5","author":"Schorey","year":"2003","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.micpath.2021.105079_bib37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.imbio.2008.01.003","article-title":"Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways","volume":"213","author":"Ho","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.micpath.2021.105079_bib38","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1128\/IAI.70.12.7165-7168.2002","article-title":"Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells","volume":"70","author":"Jarvis","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.105079_bib39","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s11033-019-04661-6","article-title":"Pro-atherogenic proteoglycanase ADAMTS-1 is down-regulated by lauric acid through PI3K and JNK signaling pathways in THP-1 derived macrophages","volume":"46","author":"Ong","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.micpath.2021.105079_bib40","doi-asserted-by":"crossref","first-page":"30536","DOI":"10.18632\/oncotarget.8867","article-title":"MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-\u03baB and NLRP3 inflammasome activation","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.micpath.2021.105079_bib41","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3389\/fimmu.2017.02013","article-title":"Brucella downregulates tumor necrosis-\u03b1 to promote intracellular survival via Omp25 regulation of different microRNAs in porcine and murine macrophages","volume":"8","author":"Luo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2180-5-22","article-title":"Interferon-\u03b3 promotes abortion due to Brucella infection in pregnant mice","volume":"5","author":"Kim","year":"2005","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2021.105079_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-\u03b3 is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2002","journal-title":"Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3855\/jidc.5155","article-title":"Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors","volume":"9","author":"Kutlu","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.micpath.2021.105079_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2021.105079_bib46","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.180.2.1080","article-title":"Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection","volume":"180","author":"Macedo","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074729","article-title":"Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice","volume":"8","author":"Corsetti","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.105079_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.188.Supp.117.20","article-title":"Anti-inflammatory role of IL-10 producing macrophages during early Brucella abortus infection","volume":"188","author":"Xavier","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.105079_bib49","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/pathogens9121040","article-title":"Lack of interleukin-6 affects IFN-\u03b3 and TNF-\u03b1 production and early in vivo control of Brucella abortus infection","volume":"9","author":"Guimaraes","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2021.105079_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00431-19","article-title":"Interleukin 6 promotes Brucella abortus clearance by controlling bactericidal activity of macrophages and CD8+ T cell differentiation","volume":"87","author":"Hop","year":"2019","journal-title":"Infect. Immun."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102100351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102100351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:39:51Z","timestamp":1760110791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102100351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"alternative-id":["S088240102100351X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105079","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.105079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105079"}}